On the public citation graph

Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study

https://doi.org/10.1371/journal.pmed.1003992
0 signed · 175 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2022.0470openalex-snapshot
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
inferredcites →https://doi.org/10.1001/jamanetworkopen.2021.31137openalex-snapshot
Protective Behaviors Against COVID-19 by Individual Vaccination Status in 12 Countries During the Pandemic
inferredcites →https://doi.org/10.1007/s10654-014-9930-3openalex-snapshot
The Danish Civil Registration System as a tool in epidemiology
inferredcites →https://doi.org/10.1016/j.eclinm.2021.100954openalex-snapshot
Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values
inferredcites →https://doi.org/10.1016/j.ijsu.2014.07.013openalex-snapshot
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
inferredcites →https://doi.org/10.1016/s0140-6736(21)02249-2openalex-snapshot
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
inferredcites →https://doi.org/10.1016/s0140-6736(22)00152-0openalex-snapshot
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
inferredcites →https://doi.org/10.1016/s0140-6736(22)00462-7openalex-snapshot
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study
inferredcites →https://doi.org/10.1038/s41467-022-33498-0openalex-snapshot
Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark
inferredcites →https://doi.org/10.1038/s41541-021-00362-zopenalex-snapshot
Benefit of COVID-19 Vaccination Accounting for Potential Risk Compensation
inferredcites →https://doi.org/10.1038/s41591-021-01548-7openalex-snapshot
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
inferredcites →https://doi.org/10.1038/s41591-022-01753-yopenalex-snapshot
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
inferredcites →https://doi.org/10.1056/nejmc2112981openalex-snapshot
Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
inferredcites →https://doi.org/10.1056/nejmoa2108891openalex-snapshot
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
inferredcites →https://doi.org/10.1056/nejmoa2114228openalex-snapshot
Waning Immunity after the BNT162b2 Vaccine in Israel
inferredcites →https://doi.org/10.1056/nejmoa2119451openalex-snapshot
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
inferredcites →https://doi.org/10.1111/apm.13140openalex-snapshot
Electronic reporting of diagnostic laboratory test results from all healthcare sectors is a cornerstone of national preparedness and control of COVID‐19 in Denmark
inferredcites →https://doi.org/10.1136/bmj-2021-069761openalex-snapshot
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
inferredcites →https://doi.org/10.1136/bmjebm-2021-111901openalex-snapshot
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies
inferredcites →https://doi.org/10.1371/journal.pmed.0040296openalex-snapshot
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
inferredcites →https://doi.org/10.17863/cam.81883openalex-snapshot
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
inferredcites →https://doi.org/10.21203/rs.3.rs-1486018/v1openalex-snapshot
Vaccine effectiveness against infection and COVID-19-associated hospitalisation with the Omicron (B.1.1.529) variant after vaccination with the BNT162b2 or mRNA-1273 vaccine: A nationwide Danish cohort study
inferredcites →https://doi.org/10.2139/ssrn.3961378openalex-snapshot
Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease: Results of a Systematic Review and Meta-Regression
inferredcites →https://doi.org/10.2147/clep.s309840openalex-snapshot
Positive Predictive Value of ICD-10 Diagnosis Codes for COVID-19
inferredcites →https://doi.org/10.2147/clep.s91125openalex-snapshot
The Danish National Patient Registry: a review of content, data quality, and research potential
inferredcites →https://doi.org/10.2807/1560-7917.es.2022.27.10.2200181openalex-snapshot
Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022
inferredcites →https://doi.org/10.2807/ese.17.17.20155-enopenalex-snapshot
The Danish vaccination register

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4460165openalex-extracted
inferred← citeshttps://doi.org/10.2139/ssrn.4463500openalex-extracted
inferred← citeshttps://doi.org/10.2139/ssrn.4526539openalex-extracted
COVID-19 Transmission Dynamics in Laos Under Non-Pharmaceutical Interventions, Vaccination, and Replacement of Variants of SARS-CoV-2 Virus: A Mathematical Modelling Study
inferred← citeshttps://doi.org/10.2139/ssrn.4615371openalex-extracted
Covid-19 Mortality: The Proportionality Hypothesis
inferred← citeshttps://doi.org/10.2139/ssrn.4627268openalex-extracted
Effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation: a nation-wide cohort study in Denmark, October 2023
inferred← citeshttps://doi.org/10.2139/ssrn.4669162openalex-extracted
NVX-CoV2373 Efficacy in Preventing SARS-CoV-2 Infection in Adolescents
inferred← citeshttps://doi.org/10.2139/ssrn.5227321openalex-extracted
Effectiveness of the BNT162b2 and mRNA-1273 JN.1-adapted Vaccines Against COVID-19-associated Hospitalisation and Death: a Danish Nationwide Register-based Cohort Study
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.10650openalex-snapshot
Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity
inferred← citeshttps://doi.org/10.1002/viw.20240075openalex-snapshot
The effectiveness and safety of azvudine treatment in COVID‐19 patients with kidney disease based on a multicenter retrospective cohort study
inferred← citeshttps://doi.org/10.1007/s00285-023-01900-0openalex-snapshot
The emergence of a virus variant: dynamics of a competition model with cross-immunity time-delay validated by wastewater surveillance data for COVID-19
inferred← citeshttps://doi.org/10.1007/s10654-026-01414-1openalex-snapshot
Dynamics of infection, vaccination and excess mortality during the COVID-19 pandemic among older individuals—a nationwide analysis
inferred← citeshttps://doi.org/10.1007/s11606-023-08254-9openalex-snapshot
The Efficacy of SARS-CoV-2 Vaccination in the Elderly: A Systemic Review and Meta-analysis
inferred← citeshttps://doi.org/10.1007/s11739-022-03162-yopenalex-snapshot
Value of hospital datasets of COVID-19 patients across different pandemic periods: challenges and opportunities
inferred← citeshttps://doi.org/10.1007/s12561-024-09417-wopenalex-snapshot
Estimate Time-To-Infection (TTI) Vaccination Effect When TTI for Unvaccinated Group is Unknown
inferred← citeshttps://doi.org/10.1016/j.ajic.2023.02.005openalex-snapshot
Effectiveness of mRNA vaccine against Omicron-related infections in the real world: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.annepidem.2024.12.008openalex-snapshot
Disparities in anti-nucleocapsid and anti-spike SARS-CoV-2 antibody prevalence in NYC — April–October 2021
inferred← citeshttps://doi.org/10.1016/j.biologicals.2024.101750openalex-snapshot
The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report
inferred← citeshttps://doi.org/10.1016/j.cegh.2024.101785openalex-snapshot
Comparative analysis of COVID-19 vaccine booster dose (VBD) acceptance among trainees and students of health professions in Bangladesh
inferred← citeshttps://doi.org/10.1016/j.gene.2024.148970openalex-snapshot
Mathematical model for understanding the relationship between diabetes and novel coronavirus
inferred← citeshttps://doi.org/10.1016/j.health.2023.100244openalex-snapshot
An optimization model with simulation for optimal regional allocation of COVID-19 vaccines
inferred← citeshttps://doi.org/10.1016/j.ijid.2023.03.022openalex-snapshot
Observed negative vaccine effectiveness could be the canary in the coal mine for biases in observational COVID-19 studies
inferred← citeshttps://doi.org/10.1016/j.ijid.2023.04.401openalex-snapshot
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.infpip.2024.100371openalex-snapshot
Refining the hospitalization rate: A mixed methods approach to differentiate primary COVID-19 from incidental cases
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2023.578215openalex-snapshot
Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis
inferred← citeshttps://doi.org/10.1016/j.lanmic.2024.100984openalex-snapshot
Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial
inferred← citeshttps://doi.org/10.1016/j.lanwpc.2023.100911openalex-snapshot
Protective effect of previous infection and vaccination against reinfection with BA.5 Omicron subvariant: a nationwide population-based study in Japan
inferred← citeshttps://doi.org/10.1016/j.pmedr.2024.102632openalex-snapshot
Vaccines reduced hospital length of stay and fraction of inspired oxygen of COVID-19 patients: A retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2023.168703openalex-snapshot
Inferring hospital admissions from SARS-CoV-2 virus loads in wastewater in The Netherlands, August 2020 – February 2022
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.02.062openalex-snapshot
Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.04.054openalex-snapshot
NVX-CoV2373 vaccine efficacy against hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.05.022openalex-snapshot
Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 – January 2022
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.07.070openalex-snapshot
Predictors of incomplete COVID-19 vaccine schedule among adults in Scotland: Two retrospective cohort analyses of the primary schedule and third dose
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.01.080openalex-snapshot
Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.04.047openalex-snapshot
BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.05.011openalex-snapshot
Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain
inferred← citeshttps://doi.org/10.1016/j.vaccine.2024.05.059openalex-snapshot
High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis
inferred← citeshttps://doi.org/10.1016/j.vaccine.2025.127273openalex-snapshot
Impact of COVID-19 vaccination by implementation timing and coverage rate in relation to misinformation prevalence in Japan
inferred← citeshttps://doi.org/10.1016/j.vaccine.2026.128394openalex-snapshot
Evidence-based assessment of safety and mechanistic questions Related to mRNA COVID-19 Vaccines
inferred← citeshttps://doi.org/10.1016/j.vaccine.2026.128490openalex-snapshot
Intranasal PIV5-vectored SARS-COV-2 KP.2 vaccine protects against homologous and heterologous challenge in mice and hamsters
inferred← citeshttps://doi.org/10.1016/j.virusres.2026.199730openalex-snapshot
From legacy to innovation: A comprehensive review of vaccine platforms against viral infections
inferred← citeshttps://doi.org/10.1016/s1473-3099(22)00595-3openalex-snapshot
Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark
inferred← citeshttps://doi.org/10.1016/s1473-3099(23)00373-0openalex-snapshot
Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study
inferred← citeshttps://doi.org/10.1016/s1473-3099(23)00746-6openalex-snapshot
Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study
inferred← citeshttps://doi.org/10.1016/s1473-3099(25)00380-9openalex-snapshot
Effectiveness of the BNT162b2 and mRNA-1273 JN.1-adapted vaccines against COVID-19-associated hospitalisation and death: a Danish, nationwide, register-based, cohort study
inferred← citeshttps://doi.org/10.1016/s2213-2600(23)00015-2openalex-snapshot
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022
inferred← citeshttps://doi.org/10.1016/s2666-5247(23)00006-xopenalex-snapshot
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study
inferred← citeshttps://doi.org/10.1017/s0950268823001188openalex-snapshot
Factors associated with the formation of SARS-CoV-2 case-clusters in Danish schools: a nationwide register-based observational study
inferred← citeshttps://doi.org/10.1017/s0950268825000354openalex-snapshot
Quantifying the direct and indirect components of COVID-19 vaccine effectiveness during the Delta variant era
inferred← citeshttps://doi.org/10.1038/s41467-022-31485-zopenalex-snapshot
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
inferred← citeshttps://doi.org/10.1038/s41467-025-60024-9openalex-snapshot
Comparative duration of neutralizing responses and protections of COVID-19 vaccination and correlates of protection
inferred← citeshttps://doi.org/10.1038/s41586-024-08477-8openalex-snapshot
SARS-CoV-2 evolution on a dynamic immune landscape
inferred← citeshttps://doi.org/10.1038/s41598-023-29334-0openalex-snapshot
Hybrid feature engineering of medical data via variational autoencoders with triplet loss: a COVID-19 prognosis study
inferred← citeshttps://doi.org/10.1038/s41598-023-47273-8openalex-snapshot
A Danish questionnaire study of acute symptoms of SARS-CoV-2 infection by variant, vaccination status, sex and age
inferred← citeshttps://doi.org/10.1038/s41598-023-51029-9openalex-snapshot
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults
inferred← citeshttps://doi.org/10.1038/s43856-024-00602-yopenalex-snapshot
Robust immune response to COVID-19 vaccination in the island population of Greenland
inferred← citeshttps://doi.org/10.1042/bst20220415openalex-snapshot
Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination
inferred← citeshttps://doi.org/10.1080/14760584.2023.2229431openalex-snapshot
Single administration vaccines: delivery challenges, in vivo performance, and translational considerations
inferred← citeshttps://doi.org/10.1080/21645515.2023.2188857openalex-snapshot
Coverage of primary and booster vaccination against COVID-19 by socioeconomic level: A nationwide cross-sectional registry study
inferred← citeshttps://doi.org/10.1080/21645515.2023.2214495openalex-snapshot
Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1080/21645515.2025.2563760openalex-snapshot
Long-term effectiveness of COVID-19 vaccination in preventing hospitalization among household contacts: A case–control study from December 2021 to April 2023
inferred← citeshttps://doi.org/10.1080/22221751.2023.2209201openalex-snapshot
Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case–control study
inferred← citeshttps://doi.org/10.1093/aje/kwae280openalex-snapshot
Tracking vaccine effectiveness in an evolving pandemic, countering misleading hot takes and epidemiologic fallacies
inferred← citeshttps://doi.org/10.1093/biostatistics/kxag002openalex-snapshot
Dynamic case-control sampling for rapid estimation of vaccine effectiveness against an emerging infectious disease variant
inferred← citeshttps://doi.org/10.1093/infdis/jiac419openalex-snapshot
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort
inferred← citeshttps://doi.org/10.1093/infdis/jiaf207openalex-snapshot
Estimating the Waning Effectiveness of COVID-19 Vaccines From Population-Level Surveillance Data in Hong Kong
inferred← citeshttps://doi.org/10.1093/lifemeta/load019openalex-snapshot
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SYS6006, as a fourth-dose booster following three doses of inactivated vaccines in healthy adults: an open-labeled Phase 1 trial
inferred← citeshttps://doi.org/10.1093/ofid/ofad073openalex-snapshot
Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine
inferred← citeshttps://doi.org/10.1093/ofid/ofae304openalex-snapshot
Performance of and Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostics Based on Symptom Onset and Close Contact Exposure: An Analysis From the Test Us at Home Prospective Cohort Study
inferred← citeshttps://doi.org/10.1097/coh.0000000000000790openalex-snapshot
The effect of HIV on COVID-19 vaccine responses
inferred← citeshttps://doi.org/10.1097/qad.0000000000003393openalex-snapshot
Outcomes following severe acute respiratory syndrome coronavirus 2 infection among individuals with and without HIV in Denmark
inferred← citeshttps://doi.org/10.1097/qad.0000000000004053openalex-snapshot
Medical mistrust and vaccine-hesitant attitudes explain SARS-CoV-2 vaccination disparities in a mixed serostatus cohort
inferred← citeshttps://doi.org/10.1098/rsif.2024.0689openalex-snapshot
Vaccine failure mode determines population-level impact of vaccination campaigns during epidemics
inferred← citeshttps://doi.org/10.1099/mgen.0.000991openalex-snapshot
Analysis of the ARTIC V4 and V4.1 SARS-CoV-2 primers and their impact on the detection of Omicron BA.1 and BA.2 lineage-defining mutations
inferred← citeshttps://doi.org/10.1101/2022.05.09.22274623openalex-snapshot
COVID-19 Vaccine effectiveness against symptomatic infection and hospitalization in Belgium, July 2021-APRIL 2022
inferred← citeshttps://doi.org/10.1101/2022.06.01.22275858openalex-snapshot
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529) dominance: A Danish nationwide study
inferred← citeshttps://doi.org/10.1101/2023.01.13.23284467openalex-snapshot
Coverage of primary and booster vaccination against COVID-19 by socioeconomic level: A nationwide cross-sectional registry study
inferred← citeshttps://doi.org/10.1101/2023.03.17.23287306openalex-snapshot
NVX-CoV2373 Vaccine Efficacy Against Hospitalization: A post hoc analysis of the PREVENT-19 phase 3, randomized, placebo-controlled trial
inferred← citeshttps://doi.org/10.1101/2025.09.29.25336864openalex-snapshot
Approaches for estimating COVID-19 vaccine effectiveness using observational data in administrative databases: a systematic review
inferred← citeshttps://doi.org/10.1111/aas.14290openalex-snapshot
Long‐term outcomes in COVID ‐19 patients admitted to intensive care in Denmark: A nationwide observational study
inferred← citeshttps://doi.org/10.1111/bcp.15644openalex-snapshot
Experience with sotrovimab treatment of SARS‐CoV‐2‐infected patients in Denmark
inferred← citeshttps://doi.org/10.1111/dom.15163openalex-snapshot
Risk of breakthrough SARS‐CoV‐2 infection and clinical outcomes among vaccinated patients with type 2 diabetes
inferred← citeshttps://doi.org/10.1111/irv.13195openalex-snapshot
Monitoring COVID‐19 vaccine effectiveness against COVID‐19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022
inferred← citeshttps://doi.org/10.1136/bmj-2022-072141openalex-snapshot
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study
inferred← citeshttps://doi.org/10.1136/bmjopen-2023-076892openalex-snapshot
Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1136/rmdopen-2024-005114openalex-snapshot
Patients with systemic autoimmune rheumatic diseases remain at risk for hospitalisation for COVID-19 infection in the Omicron era (2022–2024): a retrospective cohort study
inferred← citeshttps://doi.org/10.1155/2022/1525615openalex-snapshot
Prediction of Omicron Virus Using Combined Extended Convolutional and Recurrent Neural Networks Technique on CT-Scan Images
inferred← citeshttps://doi.org/10.11591/ijphs.v12i4.23042openalex-snapshot
Risk factors of infection with SARS-CoV-2 Omicron BA.1 in Indonesia
inferred← citeshttps://doi.org/10.1183/16000617.0222-2024openalex-snapshot
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024
inferred← citeshttps://doi.org/10.1186/s12879-026-12907-5openalex-snapshot
The role of vaccination, underlying health conditions, and working in healthcare in the socioeconomic disparities in COVID-19 hospitalization: a mediation analysis using interventional effect models
inferred← citeshttps://doi.org/10.1186/s12889-024-17790-wopenalex-snapshot
Association between vaccination rates and COVID-19 health outcomes in the United States: a population-level statistical analysis
inferred← citeshttps://doi.org/10.1186/s12889-026-27264-wopenalex-snapshot
Estimating the effect of self-protection on transmission dynamics of SARS-CoV-2 in Germany in 2021: a modelling study
inferred← citeshttps://doi.org/10.1186/s12916-024-03597-4openalex-snapshot
Evaluating the impact of extended dosing intervals on mRNA COVID-19 vaccine effectiveness in adolescents
inferred← citeshttps://doi.org/10.1186/s44263-024-00069-yopenalex-snapshot
Modelling COVID-19 transmission dynamics in Laos under non-pharmaceutical interventions, vaccination, and replacement of SARS-CoV-2 variants
inferred← citeshttps://doi.org/10.12961/aprl.2022.25.04.03openalex-snapshot
Anticuerpos postvacunales frente a SARS-CoV-2 en una cohorte de trabajadores de un hospital general
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1013524openalex-snapshot
Identifying COVID-19 peaks using early warning signals
inferred← citeshttps://doi.org/10.1371/journal.pgph.0002676openalex-snapshot
Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1371/journal.pmed.1004037openalex-snapshot
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study
inferred← citeshttps://doi.org/10.1371/journal.pone.0281395openalex-snapshot
Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study
inferred← citeshttps://doi.org/10.1371/journal.pone.0281972openalex-snapshot
Patterns of testing in the extensive Danish national SARS-CoV-2 test set-up
inferred← citeshttps://doi.org/10.1371/journal.pone.0299304openalex-snapshot
Protection of prior SARS-CoV-2 infection, COVID-19 boosters, and hybrid immunity against Omicron severe illness: A population-based cohort study of five million residents in Canada
inferred← citeshttps://doi.org/10.1371/journal.pone.0300198openalex-snapshot
Waning effectiveness of mRNA COVID-19 vaccines against inpatient and emergency department encounters
inferred← citeshttps://doi.org/10.1371/journal.pone.0306457openalex-snapshot
Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization
inferred← citeshttps://doi.org/10.1377/hlthaff.2023.00775openalex-snapshot
Global Vaccine Access Demands Combating Both Inequity And Hesitancy
inferred← citeshttps://doi.org/10.1542/peds.2023-062422openalex-snapshot
Previous Infection and Effectiveness of COVID-19 Vaccination in Middle- and High-School Students
inferred← citeshttps://doi.org/10.18203/2394-6040.ijcmph20260725openalex-snapshot
COVID-19 vaccine-elicited immune mediators and their contribution to protective immunity
inferred← citeshttps://doi.org/10.18502/ijm.v15i2.12468openalex-snapshot
Severity of SARS-CoV-2 reinfection in vaccinated healthcare workers
inferred← citeshttps://doi.org/10.20473/ijtid.v11i1.40266openalex-snapshot
Impact of Hypertension and Cardiovascular Diseases to Immune Response in COVID-19 Vaccination: A Systematic Review
inferred← citeshttps://doi.org/10.2139/ssrn.4165630openalex-snapshot
Risk of Reinfection, Vaccine Protection, and Severity of Infection with the BA.5 Omicron Subvariant: A Danish Nation-Wide Population-Based Study
inferred← citeshttps://doi.org/10.2196/65663openalex-snapshot
Strengthening Immunization Data: Protocol for the Evaluation of an Electronic Immunization Register
inferred← citeshttps://doi.org/10.2807/1560-7917.es.2023.28.26.2200768openalex-snapshot
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022
inferred← citeshttps://doi.org/10.2807/1560-7917.es.2023.28.47.2300186openalex-snapshot
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
inferred← citeshttps://doi.org/10.2807/1560-7917.es.2023.28.47.2300187openalex-snapshot
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
inferred← citeshttps://doi.org/10.2807/1560-7917.es.2024.29.28.2300697openalex-snapshot
The impact of the COVID-19 vaccination programme on symptomatic and severe SARS-CoV-2 infection during a period of Omicron variant dominance in Ireland, December 2021 to March 2023
inferred← citeshttps://doi.org/10.2807/1560-7917.es.2024.29.7.2300259openalex-snapshot
Bias in vaccine effectiveness studies of clinically severe outcomes that are measured with low specificity: the example of COVID-19-related hospitalisation
inferred← citeshttps://doi.org/10.3201/eid2904.221700openalex-snapshot
SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
inferred← citeshttps://doi.org/10.3201/eid2908.221634openalex-snapshot
Predicting COVID-19 Incidence Using Wastewater Surveillance Data, Denmark, October 2021–June 2022
inferred← citeshttps://doi.org/10.3346/jkms.2024.39.e174openalex-snapshot
Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection by Type and Frequency of Vaccine: A Community-Based Case-Control Study
inferred← citeshttps://doi.org/10.3389/fcvm.2022.998842openalex-snapshot
COVID-19 vaccine booster significantly decreases the risk of intensive care unit hospitalization in heart failure patients during the Omicron variant wave: A population-based study
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1123158openalex-snapshot
Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1244373openalex-snapshot
Study of efficacy and antibody duration to fourth-dose booster of Ad5-nCoV or inactivated SARS-CoV-2 vaccine in Chinese adults: a prospective cohort study
inferred← citeshttps://doi.org/10.3389/fpubh.2023.1107343openalex-snapshot
Impact of inactivated vaccines on decrease of viral RNA levels in individuals with the SARS-CoV-2 Omicron (BA.2) variant: A retrospective cohort study in Shanghai, China
inferred← citeshttps://doi.org/10.3389/fpubh.2023.1244662openalex-snapshot
Frequency of SARS-CoV-2 variants identified by real-time PCR in the AUNA healthcare network, Peru
inferred← citeshttps://doi.org/10.3389/fpubh.2024.1339267openalex-snapshot
Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insights
inferred← citeshttps://doi.org/10.3389/fviro.2026.1756837openalex-snapshot
Distinguishing the clinical types and laboratory markers of the ancestral and Omicron variants of COVID-19: a multicenter retrospective study
inferred← citeshttps://doi.org/10.3390/ijerph20042779openalex-snapshot
Change over Time in the Risk of Death among Japanese COVID-19 Cases Caused by the Omicron Variant Depending on Prevalence of Sublineages
inferred← citeshttps://doi.org/10.3390/life13030781openalex-snapshot
Severe Course of COVID-19 and Long-COVID-19 in Children: Difficulties in Diagnosis
inferred← citeshttps://doi.org/10.3390/pathogens12020233openalex-snapshot
Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population
inferred← citeshttps://doi.org/10.3390/pathogens12070868openalex-snapshot
Have Diagnostics, Therapies, and Vaccines Made the Difference in the Pandemic Evolution of COVID-19 in Comparison with “Spanish Flu”?
inferred← citeshttps://doi.org/10.3390/v15040844openalex-snapshot
Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia
inferred← citeshttps://doi.org/10.3390/vaccines10111914openalex-snapshot
Effectiveness of the Booster of SARS-CoV-2 Vaccine among Japanese Adolescents: A Cohort Study
inferred← citeshttps://doi.org/10.3390/vaccines10122167openalex-snapshot
Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab
inferred← citeshttps://doi.org/10.3390/vaccines11010020openalex-snapshot
Considerations in Understanding Vaccine Effectiveness
inferred← citeshttps://doi.org/10.3390/vaccines11020224openalex-snapshot
A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
inferred← citeshttps://doi.org/10.3390/vaccines11020373openalex-snapshot
Effect of COVID-19 Vaccination on the In-Hospital Prognosis of Patients Admitted during Delta and Omicron Waves in Italy
inferred← citeshttps://doi.org/10.3390/vaccines11040853openalex-snapshot
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2
inferred← citeshttps://doi.org/10.3390/vaccines11081325openalex-snapshot
COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up
inferred← citeshttps://doi.org/10.3390/vaccines11091408openalex-snapshot
Effects of Severe Acute Respiratory Syndrome Coronavirus Vaccination on Reinfection: A Community-Based Retrospective Cohort Study
inferred← citeshttps://doi.org/10.3390/vaccines12020211openalex-snapshot
Vaccine Effectiveness against SARS-CoV-2 Infection during the Circulation of Alpha, Delta, or Omicron Variants: A Retrospective Cohort Study in a Tertiary Hospital in Serbia
inferred← citeshttps://doi.org/10.3390/vaccines12040413openalex-snapshot
Estimating All-Cause Deaths Averted in the First Two Years of the COVID-19 Vaccination Campaign in Italy
inferred← citeshttps://doi.org/10.3390/vaccines12111284openalex-snapshot
Factors Predicting COVID-19 Vaccine Effectiveness and Longevity of Humoral Immune Responses
inferred← citeshttps://doi.org/10.3390/vaccines12121411openalex-snapshot
Vaccine Hesitancy and Associated Factors Amongst Health Professionals: A Scoping Review of the Published Literature
inferred← citeshttps://doi.org/10.36416/1806-3756/e20230116openalex-snapshot
Vaccination status and outcomes in critical COVID-19 patients
inferred← citeshttps://doi.org/10.38106/lmrj.2024.6.1-08openalex-snapshot
Influence of variants mutations on the progression and outcome of COVID-19 in Pakistan
inferred← citeshttps://doi.org/10.4038/cmj.v67i4.9742openalex-snapshot
Severity of SARS-CoV-2 infection among vaccinated individuals: A hospital-based study
inferred← citeshttps://doi.org/10.5694/mja2.52457openalex-snapshot
An allied health model of care for long COVID rehabilitation
inferred← citeshttps://doi.org/10.6084/m9.figshare.26669466openalex-snapshot
Additional file 1 of Association between vaccination rates and COVID-19 health outcomes in the United States: a population-level statistical analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.27012277openalex-snapshot
Additional file 1 of Evaluating the impact of extended dosing intervals on mRNA COVID-19 vaccine effectiveness in adolescents
inferred← citeshttps://doi.org/10.7326/m23-2451openalex-snapshot
Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.